Market Overview:
The global low density contrast medium market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of heart diseases and rising demand for minimally invasive procedures. In addition, technological advancements in the field of medical imaging are also contributing to the growth of this market. Based on type, the global low density contrast medium market is segmented into x-ray contrast agent, MRI contrast agent, and ultrasound contrast agent. The x-ray contrast agent segment is expected to account for the largest share of this market in 2018. This can be attributed to its high usage rates across a wide range of applications such as cardiac catheterization, angiography, and percutaneous coronary intervention (PCI). Based on application, the global low density Contrast Medium Market is divided into heart disease and interventional radiology segments.
Product Definition:
A low-density contrast medium is a substance used to improve the visibility of internal body structures during medical imaging procedures. Low-density contrast media are typically injected into a patient's veins to help make blood vessels, organs, and other internal structures more visible on an X-ray or MRI scan. The use of low-density contrast media can help physicians accurately diagnose medical problems and plan appropriate treatment strategies.
X-ray Contrast Agent:
X-ray contrast agents are used in radiography for enhancing the image quality. They are also known as low density contrast medium or X-ray absorbing solution. These solutions enhance the visibility of blood, bone and tissue structures during an X-ray examination. The market is expected to grow at a significant rate owing to increasing demand for noninvasive diagnostic imaging techniques coupled with rising awareness about various diseases and their treatment options globally.
MRI Contrast Agent:
MRI contrast agent is a radiopharmaceutical, which is used for enhancing the visibility of specific body parts during an MRI scan. The agents are injected into the patient’s body before the scan and help in providing enhanced images of blood vessels, tumors or organs. These agents act as a pooling agent for blood and other soft tissues to enhance the image quality by enhancing signal strength.
Application Insights:
The global low density contrast medium market is segmented based on application into heart disease, interventional radiology, and ultrasound. Heart disease held the largest share in 2017 owing to the increasing prevalence of cardiovascular diseases (CVDs) globally. According to a study published by The Lancet in 2016, around 1 in 3 deaths occur due to CVDs worldwide. Moreover, according to WHO around 17 million people die from CVDs every year globally and this number is expected reach 52 million by 2030 if preventive measures are not taken soon. Thus rising incidences of cardiac diseases coupled with high mortality rates are driving demand for low density contrast medium for diagnosis which will further increase adoption rate among radiologists and cardiologists across the globe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement scenario, rising prevalence of target diseases, and increasing adoption of advanced diagnostic technologies. Moreover, presence of key players in this region is also expected to drive the growth over the forecast period. For instance, GE Healthcare has a strong presence across Europe with its medical imaging business unit that offers X-ray products and solutions under brands including GE Healthcare’s Vevo range and General Electric Medical Systems’ CT/MR contrast media product line called Computed Tomography Solutions (CTS).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure coupled with growing demand for cost-effective diagnostic procedures from emerging economies like India & China.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for low density contrast media is expected to grow at a CAGR of 5.5% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which require less time and are associated with fewer complications as compared to traditional surgeries.
- Rising prevalence of cancer: The incidence of cancer is on the rise globally, which is expected to drive the demand for low density contrast media in the coming years. Low density contrast media are used in various diagnostic and therapeutic procedures such as angiography, CT scans, and MRIs that help detect tumors at an early stage.
- Technological advancements: The development of new technologies such as 3D printing has led to increased use of low density contrast media in medical procedures owing to its ability to provide high-resolution images with accurate detail visualization.. This is likely to boost the growth prospects of this market during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Low Density Contrast Medium Market Research Report
By Type
X-ray Contrast Agent, MRI Contrast Agent, Ultrasound Contrast Agent
By Application
Heart Disease, Interventional Radiology
By Companies
GE, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Daiichi Sankyo, Unijules Life Sciences, J B Chemicals and Pharmaceuticals Ltd, Sanochemia Pharmazeutika
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Low Density Contrast Medium Market Report Segments:
The global Low Density Contrast Medium market is segmented on the basis of:
Types
X-ray Contrast Agent, MRI Contrast Agent, Ultrasound Contrast Agent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Disease, Interventional Radiology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE
- Bayer
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- Lantheus
- YRPG
- BeiLu Pharma
- Daiichi Sankyo
- Unijules Life Sciences
- J B Chemicals and Pharmaceuticals Ltd
- Sanochemia Pharmazeutika
Highlights of The Low Density Contrast Medium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- X-ray Contrast Agent
- MRI Contrast Agent
- Ultrasound Contrast Agent
- By Application:
- Heart Disease
- Interventional Radiology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Low Density Contrast Medium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Low density contrast medium is a type of photographic film that has lower resolution than high density contrast medium, but it can be used to produce prints with good overall image quality.
Some of the key players operating in the low density contrast medium market are GE, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Daiichi Sankyo, Unijules Life Sciences, J B Chemicals and Pharmaceuticals Ltd, Sanochemia Pharmazeutika.
The low density contrast medium market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Low Density Contrast Medium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Low Density Contrast Medium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Low Density Contrast Medium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Low Density Contrast Medium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Low Density Contrast Medium Market Size & Forecast, 2018-2028
4.5.1 Low Density Contrast Medium Market Size and Y-o-Y Growth
4.5.2 Low Density Contrast Medium Market Absolute $ Opportunity
Chapter 5 Global Low Density Contrast Medium Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Low Density Contrast Medium Market Size Forecast by Type
5.2.1 X-ray Contrast Agent
5.2.2 MRI Contrast Agent
5.2.3 Ultrasound Contrast Agent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Low Density Contrast Medium Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Low Density Contrast Medium Market Size Forecast by Applications
6.2.1 Heart Disease
6.2.2 Interventional Radiology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Low Density Contrast Medium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Low Density Contrast Medium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Low Density Contrast Medium Analysis and Forecast
9.1 Introduction
9.2 North America Low Density Contrast Medium Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Low Density Contrast Medium Market Size Forecast by Type
9.6.1 X-ray Contrast Agent
9.6.2 MRI Contrast Agent
9.6.3 Ultrasound Contrast Agent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Low Density Contrast Medium Market Size Forecast by Applications
9.10.1 Heart Disease
9.10.2 Interventional Radiology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Low Density Contrast Medium Analysis and Forecast
10.1 Introduction
10.2 Europe Low Density Contrast Medium Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Low Density Contrast Medium Market Size Forecast by Type
10.6.1 X-ray Contrast Agent
10.6.2 MRI Contrast Agent
10.6.3 Ultrasound Contrast Agent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Low Density Contrast Medium Market Size Forecast by Applications
10.10.1 Heart Disease
10.10.2 Interventional Radiology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Low Density Contrast Medium Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Low Density Contrast Medium Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Low Density Contrast Medium Market Size Forecast by Type
11.6.1 X-ray Contrast Agent
11.6.2 MRI Contrast Agent
11.6.3 Ultrasound Contrast Agent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Low Density Contrast Medium Market Size Forecast by Applications
11.10.1 Heart Disease
11.10.2 Interventional Radiology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Low Density Contrast Medium Analysis and Forecast
12.1 Introduction
12.2 Latin America Low Density Contrast Medium Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Low Density Contrast Medium Market Size Forecast by Type
12.6.1 X-ray Contrast Agent
12.6.2 MRI Contrast Agent
12.6.3 Ultrasound Contrast Agent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Low Density Contrast Medium Market Size Forecast by Applications
12.10.1 Heart Disease
12.10.2 Interventional Radiology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Low Density Contrast Medium Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Low Density Contrast Medium Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Low Density Contrast Medium Market Size Forecast by Type
13.6.1 X-ray Contrast Agent
13.6.2 MRI Contrast Agent
13.6.3 Ultrasound Contrast Agent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Low Density Contrast Medium Market Size Forecast by Applications
13.10.1 Heart Disease
13.10.2 Interventional Radiology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Low Density Contrast Medium Market: Competitive Dashboard
14.2 Global Low Density Contrast Medium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE
14.3.2 Bayer
14.3.3 Bracco Imaging
14.3.4 Guerbet Group
14.3.5 Hengrui Medicine
14.3.6 Lantheus
14.3.7 YRPG
14.3.8 BeiLu Pharma
14.3.9 Daiichi Sankyo
14.3.10 Unijules Life Sciences
14.3.11 J B Chemicals and Pharmaceuticals Ltd
14.3.12 Sanochemia Pharmazeutika
